RARE vs SCI
Ultragenyx (RARE) versus Service Corporation International (SCI) — a side-by-side from cached financials, not a winner call.
Ultragenyx (RARE) is a biotechnology company listed on US.
Service Corporation International (SCI) is a personal services company listed on NYSE.
Latest reported RARE revenue for 2024-12-31 was $560.2M. Net income was -$569.2M. Revenue was up 29.0% from 2023-12-31 to 2024-12-31. RARE currently screens at market cap $2.79B.
Latest reported SCI revenue for 2025-12-31 was $4.31B. Net income was $542.6M. Revenue was up 2.9% from 2024-12-31 to 2025-12-31. SCI currently screens at market cap $10.01B and trailing P/E 19.1.
RARE currently screens at market cap $2.79B. SCI currently screens at market cap $10.01B and trailing P/E 19.1.
Not investment advice. Open the RARE and SCI stock pages for the full models.
Not investment advice.